Michael Cannon, MD
Rheumatology · Virginia Beach, VANPI 1215925599
Payments from drug & device makers
Across 788 payments — averaging $184.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$94K
- Pfizer$32K
- Amgen$5K
- Johnson & Johnson$3K
- AbbVie$2K
- Sanofi$2K
- plus $7K from 32 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 118 | $94,271 |
| Pfizer | 121 | $31,982 |
| Amgen(2 entities) | 126 | $5,052 |
| Johnson & Johnson(2 entities) | 35 | $3,055 |
| AbbVie | 77 | $2,274 |
| Sanofi | 6 | $1,752 |
| Lilly USA, LLC | 45 | $1,170 |
| Novartis | 45 | $1,014 |
| UCB, Inc. | 47 | $945 |
| Radius Health, Inc. | 18 | $487 |
| AstraZeneca(2 entities) | 17 | $436 |
| Aurinia Pharma U.S., Inc. | 11 | $409 |
| E.r. Squibb & Sons, L.L.C. | 18 | $331 |
| Boehringer Ingelheim | 11 | $282 |
| Mallinckrodt Hospital Products Inc. | 11 | $273 |
| Genentech USA, Inc. | 20 | $211 |
| Organon | 11 | $177 |
| Bristol Myers Squibb | 3 | $160 |
| ANI Pharmaceuticals, Inc. | 5 | $136 |
| Sobi, Inc | 5 | $128 |
| Bioventus LLC | 5 | $95 |
| Mallinckrodt Enterprises LLC | 3 | $80 |
| Sandoz | 4 | $72 |
| Octapharma USA, Inc. | 3 | $62 |
| Tersera Therapeutics LLC | 3 | $60 |
| Pharming Healthcare, Inc. | 3 | $58 |
| Fidia Pharma USA Inc. | 3 | $55 |
| Kyowa Kirin, Inc. | 2 | $45 |
| Regeneron Healthcare Solutions, Inc. | 2 | $27 |
| Fresenius Kabi USA, LLC | 2 | $27 |
| Pacira Therapeutics, Inc. | 1 | $24 |
| Invivyd Inc | 1 | $23 |
| Tonix Medicines, Inc. | 1 | $23 |
| Seqirus USA Inc | 1 | $22 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $15 |
| Ferring Pharmaceuticals Inc. | 1 | $14 |
| Hikma Pharmaceuticals USA | 1 | $12 |
| Sebela Pharmaceuticals Inc. | 1 | $12 |
How this compares
$145,271 in reported general payments places this provider in the 95th percentile of 159 rheumatology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other rheumatology in Virginia Beach
- Tatiana KeckVirginia Beach$13K
- Janice SherwoodVirginia Beach$9K
- Peter LipskyCharlottesville$1.6M
- Sharukh ShroffDanville$1.5M
- Kristi MizelleNewport News$1.2M
- Phillip KempfArlington$467K
- Adegbenga BankoleRoanoke$355K
- Michael StrachanRichmond$158K
- Karim MasriRichmond$147K
- Phong NguyenReston$127K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.